ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 39 filers reported holding ELEDON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $924,092 | -0.7% | 674,520 | -0.7% | 0.00% | – |
Q2 2023 | $930,993 | -41.9% | 679,557 | 0.0% | 0.00% | – |
Q1 2023 | $1,603,754 | +3.5% | 679,557 | 0.0% | 0.00% | – |
Q4 2022 | $1,549,390 | -17.4% | 679,557 | +0.0% | 0.00% | – |
Q3 2022 | $1,875,000 | +13.2% | 679,243 | 0.0% | 0.00% | – |
Q2 2022 | $1,657,000 | -38.1% | 679,243 | 0.0% | 0.00% | – |
Q1 2022 | $2,676,000 | -9.4% | 679,243 | +1.4% | 0.00% | – |
Q4 2021 | $2,953,000 | -28.7% | 669,700 | -0.1% | 0.00% | – |
Q3 2021 | $4,143,000 | +149.7% | 670,513 | +219.7% | 0.00% | – |
Q2 2021 | $1,659,000 | -32.6% | 209,750 | -8.8% | 0.00% | – |
Q1 2021 | $2,461,000 | – | 230,044 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 245,000 | $676,000 | 0.76% |
BVF INC/IL | 2,326,710 | $6,422,000 | 0.26% |
Cormorant Asset Management, LP | 1,223,500 | $3,377,000 | 0.24% |
Ikarian Capital, LLC | 221,830 | $612,000 | 0.12% |
JMAC ENTERPRISES LLC | 54,538 | $151,000 | 0.04% |
Woodline Partners LP | 516,675 | $1,426,000 | 0.02% |
Eversept Partners, LP | 67,743 | $186,971 | 0.02% |
INGALLS & SNYDER LLC | 51,149 | $141,000 | 0.01% |
Point72 Asset Management, L.P. | 375,000 | $1,035,000 | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 22,050 | $61,000 | 0.00% |